$1.5 Billion is the total value of Rhenman & Partners Asset Management AB's 92 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 15.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Sell | UNITED HEALTH GROUP INC | $60,532,000 | +23.9% | 120,000 | -4.0% | 4.02% | +17.4% |
| PFE | PFIZER INC | $58,400,000 | +35.8% | 1,000,000 | 0.0% | 3.88% | +28.6% | |
| LLY | Buy | LILLY ELI & CO | $47,133,000 | +40.7% | 170,000 | +17.2% | 3.13% | +33.3% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $46,011,000 | -10.6% | 425,000 | -9.6% | 3.06% | -15.3% |
| ANTM | Sell | ANTHEM INC | $45,781,000 | +2.3% | 98,000 | -18.3% | 3.04% | -3.1% |
| ABBV | Sell | ABBVIE INC | $45,537,000 | +18.9% | 335,000 | -5.6% | 3.03% | +12.6% |
| MCK | Buy | MCKESSON CORP | $44,055,000 | +49.3% | 177,000 | +19.6% | 2.93% | +41.4% |
| JNJ | Sell | JOHNSON & JOHNSON | $43,594,000 | -0.0% | 253,000 | -6.3% | 2.90% | -5.3% |
| CVS | Buy | CVS HEALTH CORP | $42,509,000 | +25.2% | 410,000 | +2.5% | 2.83% | +18.7% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $39,121,000 | +58.2% | 910,000 | +59.6% | 2.60% | +49.8% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $37,195,000 | +2.0% | 290,000 | +3.6% | 2.47% | -3.4% |
| VRTX | VERTEX PHARMACEUTICALS INC | $36,704,000 | +22.6% | 165,000 | 0.0% | 2.44% | +16.2% | |
| CI | Buy | CIGNA CORP NEW | $32,305,000 | +27.1% | 140,000 | +10.2% | 2.15% | +20.4% |
| MDT | Buy | MEDTRONIC PLC | $30,923,000 | -9.6% | 296,000 | +8.4% | 2.06% | -14.4% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $29,930,000 | +58.5% | 175,000 | +75.0% | 1.99% | +50.2% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $29,280,000 | -14.6% | 44,000 | -26.7% | 1.95% | -19.1% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $29,162,000 | +29.9% | 218,000 | +16.0% | 1.94% | +23.0% |
| BIIB | Sell | BIOGEN INC | $27,600,000 | -35.0% | 115,000 | -23.3% | 1.84% | -38.4% |
| HUM | Sell | HUMANA INC | $25,645,000 | +15.6% | 55,000 | -3.5% | 1.70% | +9.5% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $23,606,000 | +27.3% | 265,000 | +10.4% | 1.57% | +20.6% |
| MRK | MERCK & CO. INC | $23,142,000 | +2.7% | 300,000 | 0.0% | 1.54% | -2.7% | |
| BDX | Buy | BECTON DICKINSON & CO | $23,047,000 | +61.6% | 91,000 | +56.9% | 1.53% | +53.1% |
| COO | Buy | COOPER COS INC | $23,007,000 | +23.7% | 54,260 | +20.6% | 1.53% | +17.2% |
| MRTX | MIRATI THERAPEUTICS INC | $22,235,000 | -16.2% | 150,000 | 0.0% | 1.48% | -20.6% | |
| CNC | Sell | CENTENE CORP DEL | $21,417,000 | +14.6% | 255,000 | -15.0% | 1.42% | +8.5% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $20,741,000 | +10.6% | 150,000 | +11.1% | 1.38% | +4.8% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $20,619,000 | +11.5% | 430,000 | -23.4% | 1.37% | +5.6% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $20,331,000 | +26.9% | 390,000 | -9.2% | 1.35% | +20.3% |
| GILD | Sell | GILEAD SCIENCES INC | $20,174,000 | -3.7% | 275,000 | -8.3% | 1.34% | -8.8% |
| GH | Sell | GUARDANT HEALTH INC | $20,046,000 | -21.8% | 200,000 | -2.4% | 1.33% | -25.9% |
| SGEN | Sell | SEAGEN INC | $19,963,000 | -12.9% | 127,000 | -5.9% | 1.33% | -17.5% |
| ABMD | Sell | ABIOMED INC | $18,827,000 | -17.4% | 52,000 | -25.7% | 1.25% | -21.7% |
| XNCR | Sell | XENCOR INC | $18,333,000 | +10.7% | 450,000 | -11.2% | 1.22% | +4.9% |
| AXNX | Buy | AXONICS MODULATION TECHNOLOG | $17,709,000 | -6.2% | 315,000 | +8.6% | 1.18% | -11.1% |
| THC | Buy | TENET HEALTHCARE CORP | $17,201,000 | +43.8% | 210,000 | +16.7% | 1.14% | +36.4% |
| VEEV | VEEVA SYS INC | $15,601,000 | -9.8% | 60,000 | 0.0% | 1.04% | -14.6% | |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $15,370,000 | +171.8% | 580,000 | +141.7% | 1.02% | +157.4% |
| HCA | Sell | HCA HEALTHCARE INC | $15,228,000 | -16.3% | 59,000 | -21.3% | 1.01% | -20.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $14,532,000 | -26.9% | 40,000 | +100.0% | 0.97% | -30.8% |
| ABT | Sell | ABBOTT LABS | $14,100,000 | -42.1% | 100,000 | -51.5% | 0.94% | -45.1% |
| RCM | R1 RCM INC | $13,860,000 | +14.5% | 550,000 | 0.0% | 0.92% | +8.5% | |
| NKTR | NEKTAR THERAPEUTICS | $13,300,000 | -22.0% | 950,000 | 0.0% | 0.88% | -26.2% | |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $13,068,000 | +9.9% | 100,000 | -4.8% | 0.87% | +4.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $12,788,000 | +40.4% | 151,100 | +59.1% | 0.85% | +33.0% |
| DHR | New | DANAHER CORPORATION | $11,825,000 | – | 36,000 | +100.0% | 0.79% | – |
| TDOC | Sell | TELADOC HEALTH INC | $11,794,000 | -38.0% | 125,000 | -16.7% | 0.78% | -41.3% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $11,652,000 | +47.7% | 600,000 | +87.5% | 0.78% | +39.9% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $11,544,000 | -34.3% | 90,000 | -25.0% | 0.77% | -37.7% |
| IMGN | Buy | IMMUNOGEN INC | $11,175,000 | +61.7% | 1,500,000 | +23.1% | 0.74% | +53.2% |
| INSP | New | INSPIRE MED SYS INC | $10,677,000 | – | 46,373 | +100.0% | 0.71% | – |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $10,665,000 | -26.0% | 750,000 | 0.0% | 0.71% | -29.9% | |
| MGTX | MEIRAGTX HLDGS PLC | $10,454,000 | +76.3% | 450,000 | 0.0% | 0.70% | +67.1% | |
| ALGN | New | ALIGN TECHNOLOGY INC | $9,933,000 | – | 15,000 | +100.0% | 0.66% | – |
| HCAT | HEALTH CATALYST INC | $9,734,000 | -18.9% | 240,000 | 0.0% | 0.65% | -23.2% | |
| NVCR | Buy | NOVOCURE LTD | $9,610,000 | +37.9% | 120,387 | +100.6% | 0.64% | +30.7% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $9,528,000 | +21.3% | 220,000 | +7.4% | 0.63% | +15.1% |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $9,201,000 | +8.2% | 530,000 | +26.2% | 0.61% | +2.5% |
| SILK | Buy | SILK ROAD MEDICAL INC | $8,660,000 | +7.8% | 200,000 | +37.0% | 0.58% | +2.1% |
| EXAS | Sell | EXACT SCIENCES CORP | $8,568,000 | -50.1% | 110,000 | -38.9% | 0.57% | -52.7% |
| GKOS | Buy | GLAUKOS CORP | $8,022,000 | +11.0% | 175,000 | +16.7% | 0.53% | +5.1% |
| OSH | Buy | OAK STR HEALTH INC | $7,715,000 | +72.7% | 220,000 | +109.5% | 0.51% | +63.9% |
| CYTK | New | CYTOKINETICS INC | $6,840,000 | – | 150,000 | +100.0% | 0.46% | – |
| SWAV | SHOCKWAVE MEDICAL INC | $6,108,000 | -12.7% | 34,000 | 0.0% | 0.41% | -17.3% | |
| SGMO | SANGAMO THERAPEUTICS INC | $5,975,000 | -13.3% | 765,000 | 0.0% | 0.40% | -18.0% | |
| EPIX | Sell | ESSA PHARMA INC | $5,926,000 | +23.5% | 420,000 | -30.0% | 0.39% | +16.9% |
| ISEE | IVERIC BIO INC | $5,754,000 | +1.2% | 350,000 | 0.0% | 0.38% | -4.0% | |
| ACCD | Sell | ACCOLADE INC | $5,517,000 | -59.7% | 210,000 | -35.4% | 0.37% | -61.9% |
| AERI | AERIE PHARMACEUTICALS INC | $5,378,000 | -37.1% | 750,000 | 0.0% | 0.36% | -40.3% | |
| PHR | PHREESIA INC | $5,240,000 | -31.2% | 123,465 | 0.0% | 0.35% | -35.0% | |
| PGNY | Buy | PROGYNY INC | $5,194,000 | +15.9% | 101,262 | +26.6% | 0.34% | +9.9% |
| SAGE | SAGE THERAPEUTICS INC | $4,974,000 | -2.4% | 115,000 | 0.0% | 0.33% | -7.5% | |
| STXS | STEREOTAXIS INC | $4,976,000 | +15.6% | 800,000 | 0.0% | 0.33% | +9.6% | |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $4,960,000 | -33.8% | 1,000,000 | +60.7% | 0.33% | -37.3% |
| ALKS | ALKERMES PLC | $4,904,000 | -24.3% | 210,000 | 0.0% | 0.33% | -28.4% | |
| MGNX | Sell | MACROGENICS INC | $4,895,000 | -57.1% | 300,653 | -44.9% | 0.32% | -59.4% |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $4,700,000 | – | 500,000 | +100.0% | 0.31% | – |
| VRAY | VIEWRAY INC | $4,123,000 | -26.2% | 775,000 | 0.0% | 0.27% | -30.1% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $4,074,000 | -26.2% | 1,520,000 | 0.0% | 0.27% | -30.0% | |
| MYOV | MYOVANT SCIENCES LTD | $4,018,000 | -28.4% | 250,000 | 0.0% | 0.27% | -32.2% | |
| VCRA | New | VOCERA COMMUNICATIONS INC | $3,840,000 | – | 60,000 | +100.0% | 0.26% | – |
| PHAT | PHATHOM PHARMACEUTICALS INC | $3,624,000 | -39.4% | 186,210 | 0.0% | 0.24% | -42.6% | |
| GTHX | G1 THERAPEUTICS INC | $3,400,000 | -22.1% | 325,000 | 0.0% | 0.23% | -26.1% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $3,069,000 | -8.0% | 90,000 | 0.0% | 0.20% | -12.8% | |
| ANNX | ANNEXON INC | $2,903,000 | -37.6% | 250,000 | 0.0% | 0.19% | -41.0% | |
| FGEN | FIBROGEN INC | $2,824,000 | +38.2% | 200,000 | 0.0% | 0.19% | +31.5% | |
| OLK | OLINK HLDG ABsponsored ads | $2,619,000 | -22.9% | 140,000 | 0.0% | 0.17% | -26.9% | |
| IONS | IONIS PHARMACEUTICALS INC | $2,291,000 | -8.9% | 75,000 | 0.0% | 0.15% | -14.1% | |
| New | RAPID MICRO BIOSYSTEMS INC | $2,094,000 | – | 196,087 | +100.0% | 0.14% | – | |
| PIRS | PIERIS PHARMACEUTICALS INC | $1,182,000 | -23.8% | 300,000 | 0.0% | 0.08% | -27.5% | |
| INNV | INNOVAGE HLDG CORP | $741,000 | -25.3% | 150,000 | 0.0% | 0.05% | -30.0% | |
| EPZM | EPIZYME INC | $702,000 | -48.3% | 265,000 | 0.0% | 0.05% | -50.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $604,000 | -70.4% | 60,000 | 0.0% | 0.04% | -72.0% | |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -4,392 | -100.0% | -0.05% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.10% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -0.25% | – |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -85,000 | -100.0% | -0.37% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -430,000 | -100.0% | -0.38% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -125,000 | -100.0% | -0.52% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -320,000 | -100.0% | -0.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.